Denver Health
Denver, Colorado, 80204, United States
NCT Number: NCT01391585
The investigators are testing whether patients with diabetes can communicate with our health care system through text messaging. The investigators will look at how often they respond to prompts for blood pressures, blood sugars, and step counts. The investigators will also see if they come in for lab tests when prompted by text message. Also, for patients overdue for medication refills, the investigators will ask them why they have not yet called for the refill.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Denver, Colorado, 80204, United States
Patients will be sent text messages through a software interface, the Patient Relationship Manager (PRM). A registered nurse will also use PRM to receive incoming responses. Tasks will be created for her to outreach to patients who have out of range text responses or poor response rates. This intervention if a feasibility study to see if patients can communicate with the investigator's health care system and potentially utilize PRM to better manage their diabetes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In this single armed intervention, patients will receive text message prompts
Time frame: 4 months
resonse rate to blood pressure, blood sugar, and step count prompts
Time frame: 4 months
response rate to prompt for lab text by text message
Time frame: 4 months
We will analyze the responses to text message prompts in patients late for picking up medications.
Denver Health and Hospital Authority
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00628524
Arterial Occlusive Diseases, Arteriosclerosis
Homburg, Saarland, Germany
View Trial DetailsNCT02029989
Bipolar Disorder, Bipolar and Related Disorders
Duluth, Minnesota, United States
View Trial DetailsNCT03748420
Behavior, Cardiovascular Diseases
Bloomington, Minnesota, United States
View Trial DetailsNCT01142908
Cardiovascular Disease, Cardiovascular Diseases
Durham, North Carolina, United States
View Trial Details